Raltitrexed (Tomudex, ZD1694) is a novel quinazoline folate analog that selectively inhibits thymidylate synthase. Raltitrexed prevents the formation of DNA and RNA, which are required for the growth and survival of both normal cells and cancer cells.
Molecular Weight | 458.49 |
Formula | C21H22N4O6S |
CAS Number | 112887-68-0 |
Solubility (25°C) | DMSO 78 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[1] Bernard Royer, et al. Exposure-response analysis of Raltitrexed assessing liver toxicity
[2] Y Liu, et al. Raltitrexed-based chemotherapy for advanced colorectal cancer
[3] Veerle F Surmont, et al. Raltitrexed in mesothelioma
[4] Kenneth S Wilson, et al. Raltitrexed: optimism and reality
[5] E Van Cutsem, et al. Raltitrexed: current clinical status and future directions
Related DNA/RNA Synthesis Products |
---|
DTP3 TFA
DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. |
Mating Factor α (1-6)
Mating Factor α (1-6) is a mating factor produced by α-mating type cells of Saccharomyces cerevisiae and an acts as an inhibitor of the initiation of DNA synthesis in the cells. |
Polynucleotide kinase
Polynucleotide Kinase is a DNA repair enzyme. |
Tetrapeptide
Tetrapeptide, an analogue of α-MSH, induces melanin synthesis. |
Branaplam hydrochloride
Branaplam hydrochloride is an orally active, brain-permeable, selective modulator of SMN2 splicing, with an EC50 of 20 nM for SMN, and enhances full-length SMN protein and prolongs survival in a mouse model of severe spinal muscular atrophy (SMA). Branaplam hydrochloride also inhibits hERG with an IC50 of 6.3 μM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.